← back to search

Luke R. Bonser

AstraZeneca (United Kingdom) · GB
Area of research
Physiology · Immunology
Research interest
Research interests include Asthma and respiratory diseases, IL-33, ST2, and ILC Pathways, Neonatal Respiratory Health Research, and Respiratory viral infections research.
h-index
17
citations
1,866
works
36
NIH funding
primary concept
email

Recent publications

SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants
Stem Cell Reports 2023cited by 13position: middledoi
The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium
American Journal of Respiratory Cell and Molecular Biology 2022cited by 52position: firstdoi
Epithelial miR-141 regulates IL-13–induced airway mucus production
JCI Insight 2021cited by 77position: middledoi
Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
Cell stem cell 2020cited by 250position: middledoi
Flow-Cytometric Analysis and Purification of Airway Epithelial-Cell Subsets
American Journal of Respiratory Cell and Molecular Biology 2020cited by 65position: firstdoi
An airway epithelial IL-17A response signature identifies a steroid-unresponsive COPD patient subgroup
Journal of Clinical Investigation 2018cited by 105position: middledoi
Airway Mucus and Asthma: The Role of MUC5AC and MUC5B
Journal of Clinical Medicine 2017cited by 328position: firstdoi
IFN-stimulated Gene Expression, Type 2 Inflammation, and Endoplasmic Reticulum Stress in Asthma
American Journal of Respiratory and Critical Care Medicine 2017cited by 122position: middledoi
Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma
Journal of Clinical Investigation 2016cited by 221position: firstdoi
The Endoplasmic Reticulum Resident Protein AGR3. Required for Regulation of Ciliary Beat Frequency in the Airway
American Journal of Respiratory Cell and Molecular Biology 2015cited by 64position: firstdoi
Epithelial Interleukin-25 Is a Key Mediator in Th2-High, Corticosteroid-Responsive Asthma
American Journal of Respiratory and Critical Care Medicine 2014cited by 185position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David J. Erle · University of California, San Francisco9 papers (2014–2022)Lorna Zlock · University of California, San Francisco5 papers (2016–2022)Kyung Duk Koh · University of California, San Francisco4 papers (2020–2022)Walter E. Finkbeiner · University of California, San Francisco4 papers (2016–2022)Prescott G. Woodruff · Advanced ENT and Allergy3 papers (2017–2022)Nirav R. Bhakta · University of California System2 papers (2017–2021)Dan Cheng · University of San Francisco2 papers (2014–2020)Walter L. Eckalbar · University of California, San Francisco2 papers (2020–2022)Stephanie A. Christenson · Advanced ENT and Allergy2 papers (2017–2022)Kristina Johansson · University of Gothenburg2 papers (2020–2021)Joseph R. Arron · Atotech (United States)1 papers (2017–2017)Bradley W. Schroeder · Baystate Medical Center1 papers (2015–2015)Joseph L. DeRisi · California Southern University1 papers (2017–2017) · 1 papers (2022–2022)Miguel Garcia-Knight · Wellcome Sanger Institute1 papers (2020–2020)Leqian Liu · Bruker (United States)1 papers (2020–2020)Samaneh Bolourchi · Alameda Health System1 papers (2021–2021)Guohua Zhen · Huazhong University of Science and Technology1 papers (2014–2014) · 1 papers (2021–2021) · 1 papers (2022–2022)